-
Sort By
-
Newest
-
Newest
-
Oldest
Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial sent the ASX 200 (ASX:XJO) 0.7% higher on Monday. Positive news on the vaccine front support the energy and industrial sectors amid hope of a…
Pacific Equity Partners is looking to acquire 100% of the Citadel Group (ASX: CGL) in a transaction worth $503 million. PEP is planning to provide funding to help Citadel expand its global footprint and to develop new products in specialist software and critical-secure information management for its customers in healthcare, defence and national security, government…